经皮胆道内支架置入术姑息性治疗恶性梗阻性黄疸临床研究  

Percutaneous placement of endoprotheses for treatment of malignant biliary obstruction

作　　者：许哲 

机构地区：[1]呼伦贝尔市人民医院介入科,古海拉尔021008

出　　处：《中国实用医药》2011年第26期28-29,共2页China Practical Medicine

摘　　要：目的研究经皮胆道内支架置入术姑息性治疗恶性梗阻性黄疸的临床价值。方法 48例恶性梗阻性黄疸接受经皮经肝胆道内支架置入术,男:28例女:20例,胆管癌23例,胰头癌14例,胆囊癌3例,肝门区转移癌8例,共置入胆道内48枚金属内支架。结果 48例采用经皮经肝穿刺置入胆道内支架均获得成功。44例先行胆汁内外引流术后1～2周再放置金属内支架,4例因梗阻较复杂金属支架植入后仍保留引流导管3～6周后拔除引流管;44例黄疸消退满意,本组中位生存期9个月,支架植入后加局部放化疗组中位生存期18个月。结论经皮胆道内支架置入术是姑息治疗手术不能切除的恶性梗阻性黄疸的有效方法,配合动脉内灌注化疗可提高恶性阻塞患者的生存率。Objective To study the clinical Valve of percutaneous implantation of biliary endoprotheses for treatment of malignant biliary obstruction Methods 48patients with biliary stricture were teated by PTIBS.28were male and 20 were female.including hilarbiliary cancer 23 cases.pancreatic cancer14 cases gallbladder cancer 3 cases hilar metastatic cancer 8 cases 48 met allic stents were used.Results stent placement was successful in all 48 cases.44 cases began with plastic tube which was replaced with met allic stents 1-2 weeks.The external drainage catheters were removed after 3-6weeks. Four patients hed stents crossing the ampulla.In 44 cases. The median survival was 9 months.brachytherapy or radiotherapy. The median survival period was 18 months.Conclusion percutaneous placement of biliary endoprotheses was effective and safe for palliation of malignant biliary obstruction.the survival rate of malignant biliary stricture could be further improved.

关 键 词：内支架 放射学 介入性 胆管阻塞 肝外 胆管肿瘤 

分 类 号：R735[医药卫生—肿瘤]